We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

M William Audeh, MD

Associate Clinical Professor, Medicine

Director, Cancer Clinical Quality Improvement in the Division of Hematology/Oncology

Medical Director, Outpatient Cancer Center

Medical Director, Wasserman Breast Cancer Risk Reduction Program

Cedars-Sinai Medical Center
8700 Beverly Blvd
Samuel Oschin Cancer Center
Los Angeles, CA 90048

Phone:

310-423-1188

Fax:

310-423-4759

M William Audeh, MD

Associate Clinical Professor, Medicine

Director, Cancer Clinical Quality Improvement in the Division of Hematology/Oncology

Medical Director, Outpatient Cancer Center

Medical Director, Wasserman Breast Cancer Risk Reduction Program

  • IM/Hematology/Oncology

BRCA (Mutation, Positive, Carrier)

BRCA Testing (Breast and Ovarian Cancer Gene)

Breast Cancer Risk Assessment and Risk Reduction

Breast Cancers

Cancer Genetics

M. William Audeh, MD, specializes in the treatment and prevention of breast cancer, and conducts clinical and translational research related to these areas. His work uses molecular profiling of breast cancers to determine personalized treatment strategies with targeted therapies, clinical trials with molecularly targeted therapies, and genetically targeted therapies such as PARP inhibitors against cancers with DNA repair defects, such as BRCA-mutated cancers. Breast cancer risk reduction is based on personalized risk assessment (genetics, hormonal and exposure history, diagnostic testing, etc.) and appropriate interventions.

View NIH Biographical Sketch as a PDF

  • Undergraduate: Carleton College, 1977
  • Master's: University of Minnesota, 1978
  • Medical School: University of Iowa, 1982
  • Residency: Stanford Medical Center, 1986
  • Fellowship: Stanford Medical Center, 1989
  • Member, American Society of Human Genetics, 1995-present
  • Member, American Association of Cancer Research, 1989-present
  • Member, American Society of Clinical Oncology, 1986-present
  • American Cancer Society Clinical Fellowship in Oncology, 1986-1987
  • William R. Wilson Award for Excellence in Internal Medicine, 1982
  • Audeh MW. Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition. Pharmgenomics Pers Med. 2014;7:307-316.
  • Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet. 2010;376(9737):245-251.
  • Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 2010;376(9737):235-244.
  • Audeh, MW. Genetic Predisposition to Cancer – Malfunction or Maladaptation?. Horizons in Cancer Therapeutics –From Bench to Bedside. 2003;4:3-18.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to M William Audeh, MD